{"title":"Oral and injectable naltrexone both reduce drinking in hospital patients with AUD","authors":"","doi":"10.1002/pu.31335","DOIUrl":null,"url":null,"abstract":"<p>The oral and extended-release injectable formulations of naltrexone showed similar effectiveness in reducing heavy-drinking days when initiated in a hospital setting for patients with alcohol use disorder (AUD), a randomized trial has found. The study also found no significant between-group difference in acute health care utilization.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The oral and extended-release injectable formulations of naltrexone showed similar effectiveness in reducing heavy-drinking days when initiated in a hospital setting for patients with alcohol use disorder (AUD), a randomized trial has found. The study also found no significant between-group difference in acute health care utilization.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
